These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20830537)

  • 21. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
    Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Yang Z; Shi W; Zhu B; Hu S; Zhang Y; Wang M; Zhang J; Yao Z; Zhang Y
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):327-33. PubMed ID: 23092835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
    Bertagna F; Treglia G; Piccardo A; Giubbini R
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
    Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm.
    Nilsson IL; Arnberg F; Zedenius J; Sundin A
    World J Surg; 2011 Dec; 35(12):2691-7. PubMed ID: 21989645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal Thyroid Incidentalomas on
    de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
    Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
    Boeckmann J; Bartel T; Siegel E; Bodenner D; Stack BC
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):906-12. PubMed ID: 22307576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation.
    Kwak JY; Kim EK; Yun M; Cho A; Kim MJ; Son EJ; Oh KK
    AJR Am J Roentgenol; 2008 Aug; 191(2):598-603. PubMed ID: 18647938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
    Kim H; Kim SJ; Kim IJ; Kim K
    Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.
    Kim BH; Kim SJ; Kim K; Kim H; Kim SJ; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
    Ann Nucl Med; 2015 Oct; 29(8):721-9. PubMed ID: 26108700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K
    J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
    Hagenimana N; Dallaire J; Vallée É; Belzile M
    J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules.
    Kim SJ; Kim BH; Jeon YK; Kim SS; Kim IJ
    Ann Nucl Med; 2011 Jun; 25(5):347-53. PubMed ID: 21271313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
    Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
    PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
    Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
    Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
    Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
    Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH
    Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
    Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
    Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.